RESTON,
Va., Sept. 3, 2024 /PRNewswire/
-- Leidos (NYSE:LDOS), a Fortune® 500 innovation
company, was recently awarded the National Healthcare Safety
Network (NHSN) Development, Maintenance, Support, and Modernization
contract by the Centers for Disease Control and Prevention (CDC),
National Center for Emerging and Zoonotic Infectious Diseases.
Leidos will leverage its data management and mission software
expertise to continue delivering a secure NHSN platform, including
the necessary support applications and inputs from partnering
federal agencies. The contract has a total value of $51 million over a five-year period of
performance.
"NHSN is a critical cornerstone in enhancing patient safety and
healthcare delivery across the U.S.," said Liz Porter, Leidos Health & Civil Sector
President. "Since the inception of NHSN in 2003, our collaboration
with the CDC has empowered over 160,000 users at more than 38,000
facilities with reliable and actionable data. Our combined efforts
ensure the secure transmission of healthcare data across evolving
sites of care, driving improvements in patient outcomes and
fostering system modernization and efficiency."
Leidos will work to continue to advance and modernize the NHSN
application. NHSN facilitates electronic messaging directly from
electronic health records, informs rapid, tailored infection
prevention, and allows decision-makers to monitor healthcare system
capacity. Additionally, the platform tracks vaccination uptake in
healthcare settings, monitors blood safety errors, and helps
prevent the spread of emerging and enduring threats, such as
COVID-19, healthcare associated infections, and
antimicrobial-resistant infections.
The NHSN serves nearly all U.S. hospitals, nursing homes,
dialysis facilities, and ambulatory surgery centers. This contract
will extend Leidos' support in providing the critical data
necessary to understand the success of prevention efforts and
practices in healthcare, ultimately determining the quality and
safety of care delivered in U.S. healthcare facilities.
About Leidos
Leidos is a Fortune 500® innovation company rapidly
addressing the world's most vexing challenges in national security
and health. The company's global workforce of 48,000 collaborates
to create smarter technology solutions for customers in heavily
regulated industries. Headquartered in Reston, Virginia, Leidos reported annual
revenues of approximately $15.4
billion for the fiscal year ended December 29, 2023. For more information, visit
www.leidos.com.
Certain statements in this announcement constitute
"forward-looking statements" within the meaning of the rules and
regulations of the U.S. Securities and Exchange Commission
(SEC). These statements are based on management's current
beliefs and expectations and are subject to significant risks and
uncertainties. These statements are not guarantees of future
results or occurrences. A number of factors could cause our actual
results, performance, achievements, or industry results to be
different from the results, performance, or achievements expressed
or implied by such forward-looking statements. These factors
include, but are not limited to, the "Risk Factors" set forth in
Leidos' Annual Report on Form 10-K for the fiscal year ended
December 29, 2023, and other such
filings that Leidos makes with the SEC from time to time. Readers
are cautioned not to place undue reliance on such forward-looking
statements, which speak only as of the date hereof. Leidos does not
undertake to update forward-looking statements to reflect the
impact of circumstances or events that arise after the date the
forward-looking statements were made.
Contact:
Alyssa Pettus
(571) 526-6743
alyssa.t.pettus@leidos.com
Brandon VerVelde
(571) 526-6257
Brandon.p.vervelde@leidos.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/leidos-awarded-cdcs-national-health-safety-network-modernization-contract-302235551.html
SOURCE Leidos Holdings, Inc.
